

Get the latest on the Climara Pro shortage in 2026 — what's causing it, whether it's still hard to find, and how to get your prescription filled.
If you've been struggling to find Climara Pro at your pharmacy, you're dealing with a problem that's been affecting menopausal women across the country since late 2023. The once-weekly combination hormone patch — a favorite for its convenience and effectiveness — has been subject to intermittent supply constraints that have left many patients scrambling.
Here's what you need to know about the Climara Pro shortage as of 2026, including what's causing it, what it costs, and what your options are.
As of early 2026, Climara Pro is not listed as a formal shortage on the FDA's Drug Shortage Database, but that doesn't mean it's easy to find. Many patients continue to report difficulty filling prescriptions at their regular pharmacies. The issue is less about a total production halt and more about intermittent supply constraints — meaning the drug is being manufactured, but not always in quantities that match demand at every pharmacy.
Availability can vary significantly by region, pharmacy type, and timing. Some pharmacies get regular shipments; others go weeks without receiving stock.
The Climara Pro supply situation is the result of several overlapping factors:
The past few years have seen a major shift in how menopause is treated. Greater awareness — driven by media coverage, celebrity advocacy, and updated clinical guidelines — has led more women to seek hormone therapy. At the same time, there's been a growing preference for transdermal delivery (patches) over oral pills, because patches deliver hormones through the skin and bypass liver metabolism, potentially reducing the risk of blood clots.
This surge in demand has put pressure on the entire HRT patch supply chain.
Climara Pro remains a brand-name-only product manufactured exclusively by Bayer. Without generic alternatives that use the exact same formulation, there's no backup manufacturer to absorb excess demand. When Bayer's supply runs low, patients have nowhere else to turn for the identical product.
The discontinuation of the Climara patch (estradiol-only, also made by Bayer) in certain international markets in late 2023 disrupted the broader HRT patch landscape. Some patients who were on Climara were switched to combination products, further increasing demand for Climara Pro and similar medications like CombiPatch.
Transdermal patches are more complex to manufacture than pills or capsules. Issues with adhesive components, drug-release membranes, and quality control have affected multiple patch manufacturers across the industry — not just Bayer.
Without insurance, Climara Pro costs approximately $250 to $365 for a box of 4 patches (one month's supply). That makes it one of the more expensive HRT options, especially since no generic is available.
Here's a quick look at how the costs break down:
For a full breakdown of ways to save, see our guide: How to save money on Climara Pro in 2026.
While no new generic version of Climara Pro has launched, patients do have several combination HRT alternatives:
For details on each, read: Alternatives to Climara Pro if you can't fill your prescription.
If you need Climara Pro today, here's what to do:
More tips in our detailed guide: How to find Climara Pro in stock near you.
The Climara Pro shortage isn't a simple problem with a simple fix. It's the result of increased demand, sole-manufacturer dependency, and broader supply chain challenges in the HRT patch market. But while the situation is frustrating, it's manageable — especially if you stay proactive about refills, explore your pharmacy options, and know your alternatives.
Climara Pro hasn't been discontinued. Supply is moving, just not always as fast as patients need it. Use the tools available to you, stay in touch with your prescriber, and don't go without treatment.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.